Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness costCamille Bédard, Christian R. Landry, Samuel Plante et al.|Nature Microbiology|2024Cited by 42
Most azole antifungal resistance mutations in the drug target provide cross-resistance and carry no intrinsic fitness costCamille Bédard, Christian R. Landry, Jehoshua Sharma et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 6